Research Project
Grant-in-Aid for Scientific Research (C)
Intravesical bacillus Calmette-Guerin (BCG) therapy is considered the most successful immunotherapy against solid tumor of human bladder carcinoma, but the precise anti-tumor mechanism is still unknown. BCG-susceptible dendritic cells (DCs) have been thought as key cells to induce tumor-specific immunity. However, because these DCs will not be tumorcells generally and thus, they can present antigenic molecule obtained from external tumors via class II MHC molecules, by which tumor-specific class-I MHC molecule-restricted CD8-positive cytotoxoc T lymphocytes (CTLs) will not be generated. Nevertheless, recent findings demonstrated that DC-subpopulation expressing DEC-205 can present captured antigenic molecules associated with their class I MHC by “cross-presentation”. In this study, we found that we could selectively activate DEC-205-expressing DCs when they were stimulated with viable BCG. Because such viable BCG seems to be toxic to DCs, we have currently examined the non-toxic components of BCG such as micolic acid or lipoaravinomannan (LAM) and found that these BCG-derived components have a potency to stimulate DEC-205-positive DCs. Based on the observation, we are trying to provide a new safer immunotherapy for human bladder carcinoma.
All 2013 2012 2011 2010
All Journal Article (53 results) (of which Peer Reviewed: 19 results) Presentation (17 results) (of which Invited: 4 results) Book (10 results) Patent(Industrial Property Rights) (2 results)
Int. Immunol
Volume: 25(1) Pages: 11-24
Eur.J. Immunol
Volume: 43(1) Pages: 270-280
Leukemia
Volume: 27(2) Pages: 464-472
Cell. Immunol
Volume: 280(2) Pages: 138-147
J. Nippon Medical School
Volume: 80(2)(in press)
130004147220
遙か
Volume: 8(1) Pages: 39-43
黄帝内経に啓示された古代人の智慧日本東洋医学会雑誌
Volume: 64(1) Pages: 1-9
Int. Immunol.
Volume: 25 Issue: 1 Pages: 11-24
10.1093/intimm/dxs086
Eur. J. Immunol.
Volume: 43 Issue: 1 Pages: 270-280
10.1002/eji.201242654
Volume: 27 Issue: 2 Pages: 464-472
10.1038/leu.2012.213
Cell. Immunol.
Volume: 280 Issue: 2 Pages: 138-147
10.1016/j.cellimm.2012.12.008
J. Gastroenterol. Hepatol
Volume: 27(4) Pages: 823-831
Viral. Immunol
Volume: 25(2) Pages: 106-116
Immunobiology
Volume: 217(10) Pages: 951-961
Immunology
Volume: 137(3) Pages: 259-270
日本エイズ学会誌
Volume: 14(1) Pages: 1-2
臨床免疫・アレルギー科
Volume: 57(2) Pages: 269-274
Volume: 14(2) Pages: 11-14
Volume: 14(2) Pages: 15-19
セフィーロ
Volume: 5 Pages: 1-8
Volume: 58(3) Pages: 355-360
40019440062
炎症と免疫
Volume: 20(6) Pages: 638-641
Volume: 137 Issue: 3 Pages: 259-270
10.1111/imm.12005
Viral Immunol.
Volume: 25 Issue: 2 Pages: 106-116
10.1089/vim.2011.0069
Volume: 217(Jan 13, 2012 on line published) Issue: 10 Pages: 951-961
10.1016/j.imbio.2012.01.011
Biomedical Res
Volume: 32(2) Pages: 159-166
Human Immunol
Volume: 72 Pages: 783-790
Infect. Immun
Volume: 79 Pages: 4791-4801
APMIS
Volume: 120 Pages: 56-71
臨床と微生物
Volume: 38 Pages: 9-14
これからの漢方医学 (からだの科学増刊号)
J.Gastroenterol.Hepatol.
Volume: 26 Issue: 4 Pages: 823-831
10.1111/j.1440-1746.2011.06882.x
Biomed.Res.
Volume: 32 Pages: 159-166
130004470776
Human Immunol.
Volume: 72 Issue: 10 Pages: 783-790
10.1016/j.humimm.2011.06.001
Infect Immun.
Vaccine
Volume: 28S
Biomedical Res.
Volume: 31 Pages: 53-61
130004903783
J. Nippon Med. Sch
Volume: 77 Pages: 50-52
130004147029
J. Gen. Virol
Volume: 91 Pages: 773-781
J. Infect. Chemother
Volume: 16 Pages: 10-18
Volume: 130 Pages: 597-607
Cancer Immunol. Immunother
Volume: 59 Pages: 1083-1095
Blood
Volume: 116 Pages: 1124-1131
未病と抗老化
Volume: 19 Pages: 24-28
日本透析医学会誌
Volume: 43(4) Pages: 361-366
Volume: 28
J.Gen Virol.
Cancer Immunol Immunother.
Volume: 59 Pages: 1083-1195